Back to results
US 2021/0260140 A1Published application
Novel lactic acid bacteria and use thereof
AssigneesUniversity-Industry Cooperation Group of Kyungheeuniversity, Navipharm Co.Ltd
InventorsDong-Hyun Kim, Myung Joo Han
Life of this patent
Estimating the term…
Abstract
The present invention relates to Lactobacillus plantarum NK3 and Bifidobacterium longum NK49, which are novel lactic acid bacteria and, more particularly, to a composition comprising novel lactic acid bacteria useful for prevention and treatment of inflammatory diseases.
Claims16
-14. (canceled)
A method for preventing or treating inflammatory diseases comprising:
- administering to a subject in need thereof an effective amount of Bifidobacterium longum NK49 (Accession Number:
- KCCM12088P).
-20. (canceled)
A composition comprising Bifidobacterium longum NK49 (Accession Number:
- KCCM12088P) and natural carbohydrate.
Dependencies are inferred from the claim text.